Pfizer

Pfizer

Pfizer is a prominent biopharmaceutical company focused on research and development. We use scientific advancements and our extensive global resources to create innovative therapies that enhance and prolong lives. Our portfolio includes medicines and vaccines that aid in treating illnesses and preventing them before they occur, along with some of the most recognized consumer healthcare products. Every day, our team strives to address life-threatening conditions and combat some of the most challenging diseases in both developed and emerging markets. Additionally, Pfizer partners with healthcare professionals, governments, and local communities to improve access to dependable and affordable healthcare worldwide. For over 150 years, Pfizer has been committed to making a positive impact for those who depend on us. To find out more, please visit www.pfizer.com.

International
English
Corporate/Government Newsroom

Outlet metrics

Domain Authority
81
Ranking

Global

#51092

United States

#18205

Health/Biotechnology and Pharmaceuticals

#12

Traffic sources
Monthly visitors

Articles

  • Aug 27, 2024 | pfizer.com

    PfizerForAll makes managing everyday health quicker and more convenient for millions of Americans Platform is designed for patients with migraine, COVID-19 or flu, and adults seeking vaccines for preventable diseases, including COVID-19, flu, RSV and pneumococcal pneumonia End-to-end offering gives people an easier way to connect with a qualified healthcare professional the same day, find and book vaccines, receive tests and medications at home or via a preferred pharmacy, and find savings and support if prescribed a Pfizer medicine PfizerForAll works within the existing healthcare system and through a growing network of partners to simplify access via established channels and to close gaps in care Pfizer Inc. (NYSE: PFE) today introduced PfizerForAll , a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across the U.S. The new, end-to-end experience will support the millions of Americans affected annually by

  • Jul 9, 2024 | pfizer.com

    Learn how Pfizer is making clinical trials more patient-friendly with easier enrollment, focus on patient experience, and data return initiatives.

  • Mar 21, 2018 | pfizer.com | Kelly Whalen